IL82654A0 - Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon - Google Patents

Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon

Info

Publication number: IL82654A0
Authority: IL; Israel
Prior art keywords: cell carcinoma; recombinant human; basal cell; intralesionally; treatment
Prior art date: 1986-05-27

Application number

IL82654A

Other languages

English (en)

Original Assignee

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-05-27

Filing date

1987-05-26

Publication date

1987-11-30

1987-05-26 Application filed by Schering Corp filed Critical Schering Corp

1987-11-30 Publication of IL82654A0 publication Critical patent/IL82654A0/xx

Links

206010004146 Basal cell carcinoma Diseases 0.000 title abstract 2
108010047761 Interferon-alpha Proteins 0.000 title abstract 2
102000006992 Interferon-alpha Human genes 0.000 title abstract 2
108010078049 Interferon alpha-2 Proteins 0.000 abstract 1
229960003507 interferon alfa-2b Drugs 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
MIXCUJKCXRNYFM-UHFFFAOYSA-M sodium;diiodomethanesulfonate;n-propyl-n-[2-(2,4,6-trichlorophenoxy)ethyl]imidazole-1-carboxamide Chemical compound [Na+].[O-]S(=O)(=O)C(I)I.C1=CN=CN1C(=O)N(CCC)CCOC1=C(Cl)C=C(Cl)C=C1Cl MIXCUJKCXRNYFM-UHFFFAOYSA-M 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

IL82654A 1986-05-27 1987-05-26 Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon IL82654A0 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US86664486A	1986-05-27	1986-05-27

Publications (1)

Publication Number	Publication Date
IL82654A0 true IL82654A0 (en)	1987-11-30

Family

ID=25348060

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL82654A IL82654A0 (en)	1986-05-27	1987-05-26	Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon

Country Status (13)

Country	Link
EP (1)	EP0248583B1 (da)
JP (1)	JPS62289526A (da)
KR (1)	KR870010871A (da)
AT (1)	ATE100717T1 (da)
AU (1)	AU601741B2 (da)
CA (1)	CA1295243C (da)
DE (1)	DE3788899T2 (da)
DK (1)	DK264787A (da)
ES (1)	ES2061496T3 (da)
IE (1)	IE62318B1 (da)
IL (1)	IL82654A0 (da)
PH (1)	PH26198A (da)
ZA (1)	ZA873743B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5028422A (en) *	1986-05-27	1991-07-02	Schering Corporation	Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
EP0278715A3 (en) *	1987-02-09	1989-03-08	Schering Corporation	Use of human gamma interferon for treatment of basal cell carcinoma
EP0372809B1 (en) *	1988-12-01	1993-08-04	Schering Corporation	Medicament for the treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon
US5256410A (en) *	1988-12-01	1993-10-26	Schering Corporation	Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon
IL100415A0 (en) *	1990-12-21	1992-09-06	Schering Corp	Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases
CA3057768A1 (en) *	2017-03-31	2018-10-04	Accanis Biotech F&E Gmbh & Co Kg	Prevention and treatment of non-melanoma skin cancer (nmsc)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0077063B1 (en) *	1981-10-13	1988-03-16	Exovir, Inc.	Interferon-containing compositions and the use of these compositions in the treatment of herpetic infections, pre-malignant skin lesions, skin malignancies and psoriasis
AU1153083A (en) *	1982-01-15	1983-07-28	Cetus Corporation	Interferon-alpha 54
US5098703A (en) *	1982-01-15	1992-03-24	Cetus Corporation	Interferon-alpha 76
WO1983002460A1 (en) *	1982-01-15	1983-07-21	Cetus Corp	Interferon-alpha 74
US4822605A (en) *	1986-02-18	1989-04-18	Exovir, Inc.	Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like
US4853218A (en) *	1987-02-24	1989-08-01	Schering Corporation	Zinc-protamine-alpha interferon complex

1987
- 1987-05-25 CA CA000537837A patent/CA1295243C/en not_active Expired - Lifetime
- 1987-05-25 ZA ZA873743A patent/ZA873743B/xx unknown
- 1987-05-25 PH PH35292A patent/PH26198A/en unknown
- 1987-05-25 DK DK264787A patent/DK264787A/da not_active Application Discontinuation
- 1987-05-25 IE IE135887A patent/IE62318B1/en not_active IP Right Cessation
- 1987-05-25 AU AU73366/87A patent/AU601741B2/en not_active Ceased
- 1987-05-26 ES ES87304642T patent/ES2061496T3/es not_active Expired - Lifetime
- 1987-05-26 JP JP62129563A patent/JPS62289526A/ja active Pending
- 1987-05-26 KR KR870005198A patent/KR870010871A/ko not_active Ceased
- 1987-05-26 AT AT87304642T patent/ATE100717T1/de not_active IP Right Cessation
- 1987-05-26 DE DE87304642T patent/DE3788899T2/de not_active Expired - Fee Related
- 1987-05-26 IL IL82654A patent/IL82654A0/xx not_active IP Right Cessation
- 1987-05-26 EP EP87304642A patent/EP0248583B1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
DK264787A (da)	1987-11-28
EP0248583B1 (en)	1994-01-26
ES2061496T3 (es)	1994-12-16
DE3788899T2 (de)	1994-05-05
PH26198A (en)	1992-03-18
EP0248583A3 (en)	1989-10-18
EP0248583A2 (en)	1987-12-09
CA1295243C (en)	1992-02-04
ZA873743B (en)	1987-11-25
DE3788899D1 (de)	1994-03-10
KR870010871A (ko)	1987-12-18
ATE100717T1 (de)	1994-02-15
IE62318B1 (en)	1995-01-25
IE871358L (en)	1987-11-27
JPS62289526A (ja)	1987-12-16
AU7336687A (en)	1987-12-03
AU601741B2 (en)	1990-09-20
DK264787D0 (da)	1987-05-25

Legal Events

Date	Code	Title	Description
1998-04-05	RH	Patent void

Publication	Publication Date	Title
NZ212632A (en)	1991-05-28	Tumor necrosis factor, its preparation and its use
DE69032086D1 (de)	1998-04-09	Zytotoxischer Lymphozyten-Reifefaktor
NZ227944A (en)	1991-08-27	Synergistic pharmaceutical composition of a hybrid interferon and a muramylpeptide
IT1183181B (it)	1987-10-05	Derivati del 3-metil-imidazo(4,5-c)pirazolo con attivita' terapeutica e procedimento per la loropreparazione
IL102346A0 (en)	1993-01-14	Cysteine depleted il-6 muteins
EP0248583A3 (en)	1989-10-18	Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
DK0643973T3 (da)	2003-09-08	Anvendelse af humant interferon-beta til fremstilling af farmaceutiske præparater til behandling af kronisk myeloid leukæmi
ATE67783T1 (de)	1991-10-15	Homogene rekombinante immun-interferon-fragmente und diese enthaltende pharmazeutische zusammensetzungen.
IL93219A0 (en)	1990-11-05	Treatment of leukocyte dysfunction with gm-csf
ES2115582T3 (es)	1998-07-01	Preparacion y aplicaciones de interferon-gamma.
ZA884262B (en)	1990-02-28	Pharmaceutical composition for the treatment of tumors
ZA899113B (en)	1990-08-29	Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon
IL84080A0 (en)	1988-03-31	Human leukocyte interferon compositions for skin treatment
GR3006999T3 (da)	1993-06-30
EP0278715A3 (en)	1989-03-08	Use of human gamma interferon for treatment of basal cell carcinoma
HU900202D0 (en)	1990-03-28	Process for manufacturing of pharmaceutical compositions comprising gamma-interferon suitable to treatment of ovarion cancer
GR3003132T3 (en)	1993-02-17	Pharmaceutical compositions having healing activity
MY102687A (en)	1992-09-30	Novel galenical comprising a somatostatin formulations.